Literature DB >> 20493972

Expression, purification and preliminary biochemical studies of the N-terminal domain of leucine-rich repeat kinase 2.

Bin Lu1, Yujia Zhai, Chan Wu, Xiaoyun Pang, Zhiheng Xu, Fei Sun.   

Abstract

Leucine-rich repeat kinase 2 gene is a key factor for Parkinson's disease and encodes for a large protein kinase LRRK2 (280kDa) with multiple domains, including the different repeat sequences at the N-terminus such as ankyrin domain. Here, we successfully expressed and purified two kinds of LRRK2's N-terminal fragments N1 (aa12-320) and N2 (aa12-860). The purified N2 protein was identified by mass spectrometry and N1's molecular weight was determined to be 33.23kDa. Gel filtration revealed that N1 exhibits as monomer, dimer and tetramer and N2 as oligomer in solution. N1's multiple oligomeric states were further proved by native-page and cross-linking gel experiments. Circular dichroism spectrum indicated that N1 and N2 contain both alpha helixes and beta sheets. The polymerization character of LRRK2 N-terminal region would be speculated to relate with its biological function.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20493972     DOI: 10.1016/j.bbapap.2010.05.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

Review 1.  Role of LRRK2 kinase dysfunction in Parkinson disease.

Authors:  Azad Kumar; Mark R Cookson
Journal:  Expert Rev Mol Med       Date:  2011-06-13       Impact factor: 5.600

Review 2.  The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease.

Authors:  Mark R Cookson
Journal:  Nat Rev Neurosci       Date:  2010-11-19       Impact factor: 34.870

3.  Serum amyloid A 2.2 refolds into a octameric oligomer that slowly converts to a more stable hexamer.

Authors:  Yun Wang; Saipraveen Srinivasan; Zhuqiu Ye; J Javier Aguilera; Maria M Lopez; Wilfredo Colón
Journal:  Biochem Biophys Res Commun       Date:  2011-03-31       Impact factor: 3.575

4.  Models for LRRK2-Linked Parkinsonism.

Authors:  Tianxia Li; Dejun Yang; Sarah Sushchky; Zhaohui Liu; Wanli W Smith
Journal:  Parkinsons Dis       Date:  2011-04-07

5.  Sequences located within the N-terminus of the PD-linked LRRK2 lead to increased aggregation and attenuation of 6-hydroxydopamine-induced cell death.

Authors:  Neeraj Pandey; Mark T Fahey; Yuh-Jiin I Jong; Karen L O'Malley
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

6.  Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimers.

Authors:  Laura Civiero; Renée Vancraenenbroeck; Elisa Belluzzi; Alexandra Beilina; Evy Lobbestael; Lauran Reyniers; Fangye Gao; Ivan Micetic; Marc De Maeyer; Luigi Bubacco; Veerle Baekelandt; Mark R Cookson; Elisa Greggio; Jean-Marc Taymans
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

7.  A motif within the armadillo repeat of Parkinson's-linked LRRK2 interacts with FADD to hijack the extrinsic death pathway.

Authors:  Nasia Antoniou; Dimitrios Vlachakis; Anna Memou; Emmanouela Leandrou; Polytimi-Eleni Valkimadi; Katerina Melachroinou; Diane B Re; Serge Przedborski; William T Dauer; Leonidas Stefanis; Hardy J Rideout
Journal:  Sci Rep       Date:  2018-02-22       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.